• Citer

Clinical significance of CD73 expression in triple-negative breast cancer from the BIG 02-98 adjuvant phase III clinical trial

par Buisseret, Laurence ;Pommey, Sandra;Allard, Bertrand;Garaud, Soizic ;Bergeron, M.;Cousineau, I;Ameye, Laurent ;Paesmans, Marianne ;Crown, J P A;Di Leo, Angelo ;Piccart-Gebhart, Martine ;Willard-Gallo, Karen ;Sotiriou, Christos ;Stagg, John
Référence 40th San Antonio Breast Cancer Symposium (40: 05-09/12/2017: San Antonio)
Publication Non publié, 2017-12

Poster de conférence

• Détails

Titre:	Clinical significance of CD73 expression in triple-negative breast cancer from the BIG 02-98 adjuvant phase III clinical trial
Auteur:	Buisseret, Laurence; Pommey, Sandra; Allard, Bertrand; Garaud, Soizic; Bergeron, M.; Cousineau, I; Ameye, Laurent; Paesmans, Marianne; Crown, J P A; Di Leo, Angelo; Piccart-Gebhart, Martine; Willard-Gallo, Karen; Sotiriou, Christos; Stagg, John
Informations sur la publication:	40th San Antonio Breast Cancer Symposium (40: 05-09/12/2017: San Antonio)
Statut de publication:	Non publié, 2017-12
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
Langue:	Anglais